Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

41.11 +2.86 (+7.48%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna Inc

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
99 100 Next >
1 Artificial Intelligence Stock to Buy Hand Over Fist in October and 1 to Avoid
One of these players could win in AI -- and in the healthcare market, in general. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Moderna Unusual Options Activity For October 12
Via Benzinga
2 Top Biotech Stocks to Buy Right Now
Both companies are known innovators. 
Via The Motley Fool
Moderna to Report Third Quarter 2023 Financial Results on Thursday, November 2, 2023
Via ACCESSWIRE
3 Stocks That Are Down Big, But Are Due to Fall Much Further
While the search for falling stocks is an easy one, these are the ones that might not get up from the mat. 
Via InvestorPlace
The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments?
Vaccine revenue may have slipped but could still represent billions of dollars for these companies. 
Via The Motley Fool
Exposures COVID-19
These 2 Top Stocks Are Screaming Buys Right Now
These stocks are dirt cheap today. 
Via The Motley Fool
Can Moderna Achieve Its Most Ambitious Goal Yet?
Even the best of news has failed to boost Moderna shares in recent times. 
Via The Motley Fool
Big Pharma Could Transform Into BioTech Pharma
As the word itself says, biotechnology is simply technology based on biology. It uses the knowledge of cellular and biomolecular processes to develop technologies that improve our lives and overall... 
Via Benzinga
3 Shaky Stocks to Sell in October Before It’s Too Late
Investors who are concerned about the direction of the market moving forward should sell these three vulnerable stocks now. 
Via InvestorPlace
Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand
Last week, Novavax Inc (NASDAQ: NVAX) received FDA authorization for its updated COVID-19 vaccine, targeting the omicron subvariant XBB.1.5 in  
Via Benzinga
Exposures COVID-19 Product Safety
Privatized Vaccine Distribution Sparks Confusion, Payment Challenges
As the rollout of the updated COVID-19 vaccine progresses, some individuals have been surprised by requests for upfront payments ranging from $150 to $200.  
Via Benzinga
Exposures COVID-19
Intuit, Nordstrom And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by around 250 points on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
3 Pharma Stocks to Dump Before the Damage Is Done
There's never a shortage of pharma stocks to sell due to the nature of the sector, especially when compounded by current fears. 
Via InvestorPlace
Rockwell’s Heitkoetter Talks Options Strategies, “Wheel Options,” Volatility, & Value Stocks
In this video, Markus Heitkoetter, CEO of Rockwell Trading Services, explains how he began investing as a high schooler with one share of Volkswagen. 
Via Talk Markets
Rule Breaker Investing's "Market Cap Game Show" Rolls On
This episode required a tiebreaker. 
Via The Motley Fool
This Could be Novavax's Big Opportunity
Novavax has lagged behind bigger rivals in the vaccine market. 
Via The Motley Fool
3 Undervalued Healthcare Stocks to Watch as Sector Struggles
As the healthcare sector slumps, several major stocks, including Zimmer Biomet, Moderna, and Illumina, appear undervalued in contrast to their intrinsic worth. 
Via MarketBeat
Did Moderna Just Jump Ahead of Rivals in a Potential Billion-Dollar Market?
Moderna, Pfizer, and Novavax all are working on combined vaccine candidates. 
Via The Motley Fool
Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute
Biotech firm Promosome has agreed to end the lawsuit, which accused the COVID-19 vaccine manufacturers, Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX), of patent infrin 
Via Benzinga
Topics Intellectual Property Lawsuit
Exposures COVID-19 Financial Intellectual Property
Thinking Of Buying Alexandria Real Estate Equities? Here Are The Properties And Tenants You'd Add To Your Portfolio
Via Benzinga
Why Novavax Stock Fell Today
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency Use Authorization for the company's updated... 
Via Benzinga
Exposures COVID-19 Product Safety
Mainz Biomed Continues To Transform Early Cancer Detection Across The Globe
While Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) are making great progress in cancer treatments, the importance of early detection in combating this disease cannot be overstated. 
Via Benzinga
Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares
3D Medicines Inc. was trading 7.2% higher in the Hong Kong Wednesday morning session at HK$5.53 after the company announced that it is buying back up to 10% of its own stock. 
Via Benzinga
Short Sellers Are Betting Against Novavax (NVAX) Stock
Shorts are betting no one will want Novavax's Covid-19 vaccine, but the pandemic is not yet over, and NVAX stock is cheap. 
Via InvestorPlace
Exposures COVID-19
What's Going On With Moderna Stock Wednesday?
Moderna, Inc (NASDAQ: MRNA) shares are trading higher Wednesday. 
Via Benzinga
Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company's Combination Vaccine Against Influenza and COVID-19
Via ACCESSWIRE
Biotechnology Breakthroughs: 3 Biotech Stocks That Could Make Early Investors Rich
Are you looking to invest in biotechnology breakthroughs? Here are three biotech stocks that could make early investors rich. 
Via InvestorPlace
Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna
The company can now join Pfizer and Moderna in launching an updated booster in the U.S. 
Via Investor's Business Daily
Exposures COVID-19 Product Safety
Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On?
Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S. 
Via Benzinga
Exposures COVID-19 Product Safety
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.